Compare stocks
Market: US
APHAmphenol
Add stock
Ticker or company
Summary
Traffic light — 10 checks
| Check | APH6 ✓ 2 — 1 ✕ |
|---|---|
| P/E vs its history | 32,6 |
| P/E vs industry | 32,6 |
| Forward P/E | 23,4 |
| Revenue growth, YoY | +57,6% |
| EPS growth, YoY | +27,0% |
| Net margin | 18,1% |
| Net debt / EBITDA | −0,5 |
| Free cash flow | $5,12 bn |
| Share count over a year | +101,3% |
| Cash runway | n/anot needed |
Metrics
Best WorstNo mark — in between
| Metric · better | APHTTM | Industry medianTTM |
|---|---|---|
| P/E TTM ↓ | 32,6 | 34,0 |
| Forward P/E ↓ | 23,4 | 23,4 |
| PEG ↓ | 1,2 | 1,5 |
| P/S TTM ↓ | 5,8 | 4,8 |
| EV/EBITDA ↓ | 19,5 | 22,8 |
| P/FCF ↓ | 37,7 | 27,1 |
Price, %
- APHn/a
Returns
Best WorstNo mark — in between
| Period | APH |
|---|---|
| 1 year | n/a |
| 3 years | n/a |
| 5 years | n/a |
| All time | n/a |
“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.
Analysts and insiders
Best WorstNo mark — in between
| APH | |
|---|---|
| Share of “buy” | 88% |
| Beat the forecast | 4 of 4 |
| Average “surprise” | +9,1% |
| Insiders over 12 months | sales $406 m |
Details are on each stock page.